FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental surgery, and can be used to simulate acute dynamic intestinal obstruction experimentally. Laboratory rats of the Wistar line are orally administered Loperamide in dose of 0.09 mg/day per kilogram of body weight with the interval between administrations of 12 hours twice day for 3 days.
EFFECT: method provides improved reproducibility in simulating acute dynamic intestinal obstruction by oral administration of Loperamide preparation to rats, which is a non-invasive method of modeling acute dynamic intestinal obstruction.
1 cl, 1 tbl, 2 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTISPASMODIC, ANTIULCER AND ANTACID AGENT | 2021 |
|
RU2784057C1 |
| METHOD OF JEJUNAL EPITHELIUM PERAIR IN LABORATORY ANIMALS EXPOSED TO IONISING RADIATION | 2009 |
|
RU2415476C2 |
| COMPOSITION FOR BODY DETOXIFICATION | 2014 |
|
RU2591791C2 |
| METHOD FOR INCREASING REGENERATION ACTIVITY OF RAT'S INTESTINAL EPITHELIUM FOLLOWING RADIATION EXPOSURE | 2013 |
|
RU2524804C1 |
| METHOD FOR EARLY SELECTION OF ANIMAL MANAGEMENT TACTICS WITH INTESTINAL OBSTRUCTION IN EXPERIMENT | 2019 |
|
RU2714581C1 |
| METHOD TO PREVENT INFECTIOUS COMPLICATIONS IN ANIMALS UNDER EXPOSURE TO STRESS IN EXPERIMENT | 2009 |
|
RU2410101C1 |
| METHOD OF MODELING DUODENAL FISTULA IN RABBITS | 2017 |
|
RU2650595C1 |
| METHOD OF MODELLING ENTEROENTEROANASTOMOSIS IN SMALL LABORATORY ANIMALS | 2012 |
|
RU2535411C2 |
| LIPID COMPOSITION FOR TREATING GASTROINTESTINAL DISORDERS AND ACTIVATION OF INTESTINAL DEVELOPMENT AND MATURATION | 2008 |
|
RU2469545C2 |
| AGENT, USE THEREOF AND A METHOD OF INCREASING RESISTANCE OF A MAMMALIAN ORGANISM TO ISCHEMIC-REPERFUSION INVOLVEMENT OF THE SMALL INTESTINE | 2018 |
|
RU2729788C2 |
